美国新生血管性年龄相关性黄斑变性临床试验的地理可及性差异
该回顾性横断面研究分析美国 census tract 与 ClinicalTrials.gov 数据,计算居民到最近 nAMD 临床试验点的驾车距离和时间。共识别 42 项试验、829 个试验点。多变量模型显示农村、中西部和南部地区以及教育程度较低与距离>60 英里风险升高相关,而黑人、西班牙裔和亚裔比例较高及贫困率较低与风险降低相关。
要点
- 农村居民到最近 nAMD 试验点的距离>60 英里风险显著升高(aOR 5.54)。
- 中西部和南部地区较东北部距离>60 英里风险更高(aOR 2.30 和 2.43)。
- 黑人、西班牙裔和亚裔比例较高与距离>60 英里风险降低相关。
核心结论
- 美国 nAMD 临床试验点存在地理可及性差异,农村和中西部/南部地区居民更可能需要长途驾车。
研究设计与样本
- 回顾性横断面研究,分析 census tract 级公开数据与 ClinicalTrials.gov 试验数据。
- 识别 42 项 nAMD 试验,覆盖美国 829 个 unique 临床试验点。
- 计算从人口加权 census tract 质心到最近试验点的驾车距离(>60 英里)和时间(>60 分钟)。
主要发现
- 距离>60 英里与农村位置显著相关(aOR 5.54;95%CI 3.86-7.96,P<.0001)。
- 距离>60 英里与中西部(aOR 2.30;95%CI 1.21-4.38,P=.01)和南部(aOR 2.43;95%CI 1.21-4.91,P=.01)较东北部显著相关。
- 距离>60 英里与 some college 或 associate's degree 较 bachelor's degree 显著相关(aOR 1.02;95%CI 1.01-1.04,P=.0007;aOR 1.05;95%CI 1.00-1.10,P=.04)。
- 黑人(aOR 0.98;95%CI 0.97-0.99,P<.0001)、西班牙裔(aOR 0.97;95%CI 0.95-0.99,P=.002)和亚裔(aOR 0.90;95%CI 0.88-0.93,P<.0001)比例较高及贫困率较低与距离>60 英里风险降低相关。
- 时间>60 分钟的预测因素与距离>60 英里相似。
临床怎么用
- 转诊 nAMD 患者参加临床试验时,应评估居住地到试验点的驾车距离和时间。
- 对农村及中西部/南部地区患者,可优先考虑就近试验点或远程随访模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: To identify geographic and socioeconomic variables predictive of residential proximity to neovascular age-related macular degeneration (nAMD) clinical trial locations. DESIGN: Retrospective, cross-sectional study. METHODS: Census tract-level data from public datasets and trial-level data from ClinicalTrials.gov were analyzed. We calculated the driving distance (>60 miles) and time (>60 minutes) from the population-weighted US census tract centroid to the nearest clinical trial site. RESULTS: We identified 42 trials studying nAMD across 829 unique clinical trial sites in the United States. In a multivariable model, driving distance >60 miles had a significant association with rural location (adjusted odds ratio [aOR] 5.54; 95% confidence interval [CI] 3.86-7.96, P < .0001) and with Midwest (aOR 2.30; 95% CI 1.21-4.38, P = .01) and South (aOR 2.43; 95% CI 1.21-4.91, P = .01) as compared to the Northeast region, and with some college or an associate's degree, as compared to a bachelor's degree (aOR 1.02; 95% CI 1.01-1.04, P = .0007, and aOR 1.05; 95% CI 1.00-1.10, P = .04, respectively). Lower odds of traveling >60 miles to the nearest nAMD trial site were associated with census tracts with a higher percentage of blacks (aOR 0.98; 95% CI 0.97-0.99, P < .0001), Hispanics (aOR 0.97; 95% CI 0.95-0.99, P = .002), and Asians (aOR 0.90; 95% CI 0.88-0.93, P < .0001), as compared to whites, and with a lower percentage of the population <200% of the federal poverty level. Similar predictors were found in time traveled >60 minutes. CONCLUSIONS: There are geographic access disparities of clinical trial sites for nAMD in the United States.
引用
- Soares RR, Gopal AD, Parikh D, et al. Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States. Am J Ophthalmol. 2021. PMID: 33848533. doi:10.1016/j.ajo.2021.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。